Gubra A/S Logo

Gubra A/S

Preclinical CRO and peptide drug developer for metabolic and fibrotic diseases.

GUBRA | CO

Overview

Corporate Details

ISIN(s):
DK0062266474
LEI:
254900T17RRFZONO6W53
Country:
Denmark
Address:
Hørsholm Kongevej 11 B, 2970 Hørsholm
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Gubra is a biotechnology company and preclinical Contract Research Organization (CRO) founded in 2008. The company operates a dual business model, providing specialized preclinical research services while simultaneously developing its own pipeline of peptide-based therapeutics. Gubra's core expertise lies in metabolic diseases (such as obesity, diabetes, and MASH) and fibrotic diseases. Its CRO services support pharmaceutical and biotech clients with advanced studies, including in vivo pharmacology and peptide chemistry. The drug discovery division focuses on advancing a proprietary portfolio of novel drug candidates, with research and development efforts also extending into inflammatory, CNS, respiratory, and women's health conditions. This integrated approach combines stable service revenue with the long-term potential of therapeutic innovation.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Gubra A/S and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Gubra A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Gubra A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Biophytis S.A. Logo
Develops oral drugs for age-related neuromuscular, retinal, and metabolic diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and organ repair.
Belgium BIOS
Biosergen AB Logo
Develops innovative therapies for fungal infections in immunocompromised patients.
Sweden BIOSGN
BIOTECH Logo
Biotech group offering preclinical research, gene therapy tech, and human/animal health assets.
Spain BST
Bioversys N Logo
Developing novel drugs to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV
Bonus BioGroup Ltd. Logo
Develops cell therapies and engineered bone grafts for tissue regeneration and inflammation.
Israel BONS
BRAIN Biotech AG Logo
Industrial biotech specialist developing custom enzymes & biosolutions for food & life sciences.
Germany BNN
CAMBRIDGE COGNITION HOLDINGS PLC Logo
Digital brain health assessment platform for CNS clinical trials and research.
United Kingdom COG
Can-Fite BioPharma Ltd. Logo
Develops oral drugs targeting A3AR for oncology, inflammatory, and metabolic diseases.
Israel CANF
Cannabotech Ltd. Logo
Develops botanical medical solutions from cannabinoids & mushrooms for healthcare and wellness.
Israel CNTC

Talk to a Data Expert

Have a question? We'll get back to you promptly.